Ignite Creation Date:
2025-12-18 @ 4:46 AM
Ignite Modification Date:
2025-12-23 @ 10:58 PM
Study NCT ID:
NCT00738296
Status:
None
Last Update Posted:
2015-06-24 00:00:00
First Post:
2008-08-18 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Vytorin on Carotid Intima-media Thickness and Overall Rigidity
Sponsor:
None
Organization:
Study Overview
Official Title:
Vytorin on Carotid Intima-media Thickness and Overall Rigidity
Status:
None
Status Verified Date:
2008-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VYCTOR
Brief Summary:
Comparison of the effect on the progression of the carotid intima-media interphase thickness (GIM), arterial rigidity according to the measurement of the pulse wave speed and direct measurement of the carotid and aortic rigidities and an inflammation marker (PCR) in patients with established cardiovascular disease (myocardial infarct, atherosclerotic coronary disease), diabetes mellitus type 2 or equivalent risk of coronary disease and a low density lipoprotein level \> 100 mg/dL, treated with simvastatin, pravastatin or the combination of simvastatin-ezetimibe during a period of at least one year.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: